• An Open-Label Trial of Donepezil (Aricept) in the Treatment of Persons With Mild Traumatic Brain Injury – Dr. Neil S. Kaye MD, PA

Skip to content

Dr. Neil S. Kaye MD, PA

Board Certified Forensic Psychiatrist

Back to Main
About
News
Curriculum Vitae
Rates
Contact
Menu

Post navigation

← • Recognizing, managing and treating Bipolar Disorders at the interface of Primary Care and Psychiatric Medicine (All Key PDF Page)

• Effect of Open-Label Lamotrigine as Monotherapy and Adjunctive Therapy on the Self-Assessed Cognitive Function Scores of Patients With Bipolar I Disorder →

• An Open-Label Trial of Donepezil (Aricept) in the Treatment of Persons With Mild Traumatic Brain Injury

Posted on March 13, 2019 by nskaye

An Open-Label Trial of Donepezil (Aricept) in the Treatment of Persons With Mild Traumatic Brain Injury

Posted in Articles | Tagged An Open-Label Trial, Antipsychotics, Anxiety disorders, Behavioral analysis, bipolar, Brain fog, Brain Injury, Car accident, Court Psychiatry, Criminal responsibility, Defense, Defense medical exam, Donepezil, ethics, expert witness, Family law, Forensic Psychiatry, Head injury, in the Treatment of Persons With Mild Traumatic, Independent medical exam, Law and mental health, Malpractice, Medical record review, Mild Traumatic Brain Injury, Mood disorders, Motor vehicle accident, Neuropsychiatry, Pain, Personal injury, Personality disorder, Plaintiff, Prosecution, psychiatrist, Psychiatry, Psychiatry Competency, Psychiatry Criminal defense, Psychiatry Pharmacology, Psychiatry Standard of care, Psychiatry Testimony, Psychic harm, Psychopharmacology, PTSD, Regulatory law, Right to refuse treatment, Right to treatment, Schizophrenia, Sexual offender, suicide, Trauma, Traumatic brain injury (TBI), Violence, Workers Compensation, Workplace fitness

Post navigation

← • Recognizing, managing and treating Bipolar Disorders at the interface of Primary Care and Psychiatric Medicine (All Key PDF Page)

• Effect of Open-Label Lamotrigine as Monotherapy and Adjunctive Therapy on the Self-Assessed Cognitive Function Scores of Patients With Bipolar I Disorder →

Latest News

• To meet with a defendant or a defendant’s family if they request to debrief after the verdict in a criminal case ?
• Discussion of counter-transference and forensic evaluations
• Driving Under the Influence of Cannabis : Forensic Issues
• Counter-Transference and Forensic Evaluations
• Family Law – Ethics
• What are the pros and cons of doing only expert witness work and not being an active practitioner?
• AAPL: Ask the Experts- 01-2022
• Lengthy Detailed Discovery Requests
• Medicine’s Big Lie
• Advice: Forensic Aspects Applications of Telemedicine
• Election source of stress, anxiety
• How Do You Define “Expert?”
• Dr. Kaye Recieves 2020 NAMI Exemplary Psychiatrist Award,
• Doctors can’t predict time of death, so how can they aid suicide?
• AAPL: Ask The Experts January 2020 – Tips or “come-backs” that might help me manage cross-examination?
• Testamentary Capacity
• Abnormal Illness Behavior-The Missing Link in DSM 5
• Informed Consent
• How to Choose a Doctor
• Defining, Recognizing and treating bipolar disorders wherever patients present

An Introduction from Dr. Kaye

Categories

Articles
Uncategorized

Dr. Neil S. Kaye MD, PA , Hockessin, DE 19707. 302-234-8950

Copyright © 2024 Dr. Neil S. Kaye MD, PA All Rights Reserved.

Catch Everest Theme by Catch Themes